GMAB logo

Genmab A/S (GMAB) Cash from investing

annual CFI:

-$1.44B-$1.25B(-672.38%)
December 31, 2024

Summary

  • As of today (August 23, 2025), GMAB annual cash flow from investing activities is -$1.44 billion, with the most recent change of -$1.25 billion (-672.38%) on December 31, 2024.
  • During the last 3 years, GMAB annual CFI has fallen by -$1.28 billion (-840.68%).
  • GMAB annual CFI is now -886.34% below its all-time high of $182.71 million, reached on December 31, 2009.

Performance

GMAB Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

quarterly CFI:

$25.89M+$68.92M(+160.18%)
June 1, 2025

Summary

  • As of today (August 23, 2025), GMAB quarterly cash flow from investing activities is $25.89 million, with the most recent change of +$68.92 million (+160.18%) on June 1, 2025.
  • Over the past year, GMAB quarterly CFI has increased by +$1.30 billion (+102.04%).
  • GMAB quarterly CFI is now -89.65% below its all-time high of $250.20 million, reached on June 30, 2021.

Performance

GMAB quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

TTM CFI:

$17.42M+$1.30B(+101.36%)
June 1, 2025

Summary

  • As of today (August 23, 2025), GMAB TTM cash flow from investing activities is $17.42 million, with the most recent change of +$1.30 billion (+101.36%) on June 1, 2025.
  • Over the past year, GMAB TTM CFI has increased by +$1.41 billion (+101.25%).
  • GMAB TTM CFI is now -92.46% below its all-time high of $231.01 million, reached on September 30, 2009.

Performance

GMAB TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GMAB Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-672.4%+102.0%+101.3%
3 y3 years-840.7%+131.4%+103.5%
5 y5 years-383.3%-80.8%+143.3%

GMAB Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-840.7%at low-82.3%+102.0%at high+101.2%
5 y5-year-840.7%at low-89.7%+102.0%at high+101.2%
alltimeall time-886.3%at low-89.7%+102.0%-92.5%+101.2%

GMAB Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$25.89M(-160.2%)
$17.42M(-101.4%)
Mar 2025
-
-$43.03M(-764.6%)
-$1.28B(-11.5%)
Dec 2024
-$1.44B(+672.4%)
$6.47M(-76.9%)
-$1.44B(-4.5%)
Sep 2024
-
$28.08M(-102.2%)
-$1.51B(+8.5%)
Jun 2024
-
-$1.27B(+505.1%)
-$1.39B(+255.3%)
Mar 2024
-
-$209.77M(+237.9%)
-$392.68M(+112.5%)
Dec 2023
-$186.01M(-52.3%)
-$62.08M(-142.5%)
-$184.79M(+37.7%)
Sep 2023
-
$146.20M(-154.7%)
-$134.17M(-71.6%)
Jun 2023
-
-$267.03M(>+9900.0%)
-$473.04M(+64.0%)
Mar 2023
-
-$1.87M(-83.7%)
-$288.45M(-25.5%)
Dec 2022
-$390.05M(+155.4%)
-$11.47M(-94.0%)
-$387.14M(-8.5%)
Sep 2022
-
-$192.67M(+133.7%)
-$423.12M(-14.1%)
Jun 2022
-
-$82.44M(-18.0%)
-$492.33M(+208.3%)
Mar 2022
-
-$100.56M(+111.9%)
-$159.69M(+4.4%)
Dec 2021
-$152.73M(-57.5%)
-$47.45M(-81.9%)
-$152.90M(-30.9%)
Sep 2021
-
-$261.88M(-204.7%)
-$221.29M(-35.1%)
Jun 2021
-
$250.20M(-366.8%)
-$341.12M(-25.2%)
Mar 2021
-
-$93.77M(-19.0%)
-$456.30M(+26.3%)
Dec 2020
-$359.52M(+20.9%)
-$115.84M(-69.7%)
-$361.20M(-12.9%)
Sep 2020
-
-$381.71M(-382.7%)
-$414.72M(+931.1%)
Jun 2020
-
$135.02M(>+9900.0%)
-$40.22M(-86.2%)
Mar 2020
-
$1.33M(-100.8%)
-$292.11M(-1.1%)
Dec 2019
-$297.27M(+5.7%)
-$169.35M(+2247.0%)
-$295.49M(+36.5%)
Sep 2019
-
-$7.22M(-93.8%)
-$216.51M(-20.6%)
Jun 2019
-
-$116.87M(+5575.9%)
-$272.74M(+58.9%)
Mar 2019
-
-$2.06M(-97.7%)
-$171.67M(-39.2%)
Dec 2018
-$281.36M(+177.9%)
-$90.37M(+42.4%)
-$282.30M(+49.1%)
Sep 2018
-
-$63.44M(+301.5%)
-$189.30M(+50.6%)
Jun 2018
-
-$15.80M(-86.0%)
-$125.69M(-20.8%)
Mar 2018
-
-$112.68M(-4386.0%)
-$158.70M(+56.3%)
Dec 2017
-$101.23M(-32.8%)
$2.63M(+1510.0%)
-$101.52M(-42.2%)
Sep 2017
-
$163.30K(-100.3%)
-$175.68M(-2.6%)
Jun 2017
-
-$48.81M(-12.1%)
-$180.31M(+5.6%)
Mar 2017
-
-$55.51M(-22.4%)
-$170.73M(+12.8%)
Dec 2016
-$150.74M(+110.8%)
-$71.53M(+1502.8%)
-$151.40M(+83.8%)
Sep 2016
-
-$4.46M(-88.6%)
-$82.39M(-2.3%)
Jun 2016
-
-$39.23M(+8.4%)
-$84.31M(+43.9%)
Mar 2016
-
-$36.18M(+1336.4%)
-$58.57M(-18.6%)
Dec 2015
-$71.49M(-60.2%)
-$2.52M(-60.5%)
-$71.93M(+28.8%)
Sep 2015
-
-$6.38M(-52.7%)
-$55.85M(-41.2%)
Jun 2015
-
-$13.49M(-72.8%)
-$94.91M(-33.8%)
Mar 2015
-
-$49.54M(-465.2%)
-$143.44M(-20.8%)
Dec 2014
-$179.84M(-1608.9%)
$13.56M(-129.9%)
-$181.00M(-0.2%)
Sep 2014
-
-$45.44M(-26.7%)
-$181.39M(+16.2%)
Jun 2014
-
-$62.03M(-28.8%)
-$156.12M(+61.7%)
Mar 2014
-
-$87.10M(-761.2%)
-$96.52M(-911.3%)
Dec 2013
$11.92M(-116.6%)
$13.17M(-165.3%)
$11.90M(-110.1%)
Sep 2013
-
-$20.16M(+728.7%)
-$117.51M(+30.2%)
Jun 2013
-
-$2.43M(-111.4%)
-$90.26M(+23.7%)
Mar 2013
-
$21.32M(-118.3%)
-$72.95M(+1.6%)
Dec 2012
-$71.84M
-$116.23M(-1740.0%)
-$71.80M(-256.6%)
Sep 2012
-
$7.09M(-52.4%)
$45.85M(-36.6%)
Jun 2012
-
$14.88M(-33.7%)
$72.33M(-14.2%)
DateAnnualQuarterlyTTM
Mar 2012
-
$22.46M(+1481.2%)
$84.31M(-12.9%)
Dec 2011
$96.09M(-173.3%)
$1.42M(-95.8%)
$96.77M(+120.4%)
Sep 2011
-
$33.56M(+24.9%)
$43.90M(-133.9%)
Jun 2011
-
$26.86M(-23.1%)
-$129.35M(+28.7%)
Mar 2011
-
$34.92M(-167.9%)
-$100.48M(-23.3%)
Dec 2010
-$131.06M(-171.7%)
-$51.44M(-63.2%)
-$131.06M(+20.7%)
Sep 2010
-
-$139.69M(-350.7%)
-$108.61M(-165.3%)
Jun 2010
-
$55.73M(+1182.7%)
$166.39M(+50.7%)
Mar 2010
-
$4.34M(-115.0%)
$110.41M(-39.6%)
Dec 2009
$182.71M(+101.5%)
-$29.00M(-121.4%)
$182.71M(-20.9%)
Sep 2009
-
$135.31M(<-9900.0%)
$231.01M(+132.2%)
Jun 2009
-
-$255.60K(-100.3%)
$99.49M(-26.4%)
Mar 2009
-
$76.65M(+297.2%)
$135.20M(+49.1%)
Dec 2008
$90.69M(-120.7%)
-
-
Dec 2008
-
$19.30M(+408.6%)
$90.69M(-2.9%)
Sep 2008
-
$3.79M(-89.3%)
$93.36M(+44.7%)
Jun 2008
-
$35.46M(+10.4%)
$64.52M(-115.3%)
Mar 2008
-
$32.13M(+46.3%)
-$421.77M(-3.5%)
Dec 2007
-$437.19M(+471.0%)
-
-
Dec 2007
-
$21.97M(-187.7%)
-$437.19M(+0.4%)
Sep 2007
-
-$25.05M(-94.4%)
-$435.27M(+8.5%)
Jun 2007
-
-$450.82M(-2798.0%)
-$401.15M(-747.6%)
Mar 2007
-
$16.71M(-30.1%)
$61.94M(-180.9%)
Dec 2006
-$76.57M(+260.9%)
-
-
Dec 2006
-
$23.89M(+163.4%)
-$76.57M(-7.4%)
Sep 2006
-
$9.07M(-26.1%)
-$82.73M(-43.5%)
Jun 2006
-
$12.27M(-110.1%)
-$146.41M(-2.8%)
Mar 2006
-
-$121.80M(-786.8%)
-$150.69M(+610.4%)
Dec 2005
-$21.21M(+404.6%)
-
-
Dec 2005
-
$17.73M(-132.5%)
-$21.21M(-46.1%)
Sep 2005
-
-$54.62M(-783.5%)
-$39.33M(+76.0%)
Jun 2005
-
$7.99M(+4.0%)
-$22.35M(+26.5%)
Mar 2005
-
$7.68M(-2122.3%)
-$17.67M(-19.1%)
Dec 2004
-$4.20M(-107.6%)
-
-
Dec 2004
-
-$379.80K(-99.0%)
-$21.84M(+622.9%)
Sep 2004
-
-$37.64M(-397.2%)
-$3.02M(-109.2%)
Jun 2004
-
$12.67M(+260.3%)
$33.01M(-17.2%)
Mar 2004
-
$3.52M(-80.9%)
$39.87M(-28.3%)
Dec 2003
$55.57M(+82.1%)
-
-
Dec 2003
-
$18.44M(-1248.8%)
$55.57M(+49.6%)
Sep 2003
-
-$1.60M(-108.2%)
$37.14M(-27.4%)
Jun 2003
-
$19.53M(+1.6%)
$51.16M(+58.6%)
Mar 2003
-
$19.22M(+54.7%)
$32.25M(-46.3%)
Dec 2002
$30.52M(+1.4%)
-
-
Sep 2002
-
$12.42M(+1922.1%)
$60.07M(+5.9%)
Jun 2002
-
$614.20K(-98.0%)
$56.71M(-5.0%)
Mar 2002
-
$30.02M(+76.5%)
$59.67M(+99.0%)
Dec 2001
$30.10M(-113.8%)
$17.01M(+87.8%)
$29.99M(+131.1%)
Sep 2001
-
$9.06M(+153.4%)
$12.98M(+231.1%)
Jun 2001
-
$3.58M(+938.4%)
$3.92M(+1038.4%)
Mar 2001
-
$344.30K
$344.30K
Dec 2000
-$218.45M(+2941.6%)
-
-
Dec 1999
-$7.18M
-
-

FAQ

  • What is Genmab A/S annual cash flow from investing activities?
  • What is the all time high annual CFI for Genmab A/S?
  • What is Genmab A/S annual CFI year-on-year change?
  • What is Genmab A/S quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Genmab A/S?
  • What is Genmab A/S quarterly CFI year-on-year change?
  • What is Genmab A/S TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Genmab A/S?
  • What is Genmab A/S TTM CFI year-on-year change?

What is Genmab A/S annual cash flow from investing activities?

The current annual CFI of GMAB is -$1.44B

What is the all time high annual CFI for Genmab A/S?

Genmab A/S all-time high annual cash flow from investing activities is $182.71M

What is Genmab A/S annual CFI year-on-year change?

Over the past year, GMAB annual cash flow from investing activities has changed by -$1.25B (-672.38%)

What is Genmab A/S quarterly cash flow from investing activities?

The current quarterly CFI of GMAB is $25.89M

What is the all time high quarterly CFI for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from investing activities is $250.20M

What is Genmab A/S quarterly CFI year-on-year change?

Over the past year, GMAB quarterly cash flow from investing activities has changed by +$1.30B (+102.04%)

What is Genmab A/S TTM cash flow from investing activities?

The current TTM CFI of GMAB is $17.42M

What is the all time high TTM CFI for Genmab A/S?

Genmab A/S all-time high TTM cash flow from investing activities is $231.01M

What is Genmab A/S TTM CFI year-on-year change?

Over the past year, GMAB TTM cash flow from investing activities has changed by +$1.41B (+101.25%)
On this page